These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 32592517)

  • 1. Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction.
    Yamanaka S; Sakata Y; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Fujihashi T; Hayashi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2020 Dec; 22(12):2258-2268. PubMed ID: 32592517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-stratified profiles and outcomes of patients with heart failure with preserved ejection fraction.
    Yamanaka S; Nochioka K; Hayashi H; Shiroto T; Takahashi J; Miyata S; Yasuda S; Shimokawa H;
    ESC Heart Fail; 2024 Aug; 11(4):2223-2233. PubMed ID: 38627993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
    Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
    ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Gonadectomy and Angiotensin II Receptor Blockade in a Mouse Model of Isoproterenol-induced Cardiac Diastolic Dysfunction.
    Asai K; Murai K; Shirakabe A; Kamiya M; Noma S; Sato N; Mizuno K; Shimizu W
    J Nippon Med Sch; 2021 May; 88(2):113-120. PubMed ID: 32475904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic implications of left ventricular dilatation in heart failure.
    Kasa G; Teis A; Juncà G; Aimo A; Lupón J; Cediel G; Santiago-Vacas E; Codina P; Ferrer-Sistach E; Vallejo-Camazón N; López-Ayerbe J; Bayés-Genis A; Delgado V
    Eur Heart J Cardiovasc Imaging; 2024 May; 25(6):849-856. PubMed ID: 38246859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of the established criteria for heart failure with preserved ejection fraction using the Alberta HEART cohort.
    Ezekowitz JA; McAlister FA; Howlett J; Alemayehu W; Paterson I; Belenkie I; Oudit GY; Kaul P; Dyck JR; Anderson T;
    ESC Heart Fail; 2018 Feb; 5(1):19-26. PubMed ID: 28741909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse wave signal-driven machine learning for identifying left ventricular enlargement in heart failure patients.
    Wu D; Ono R; Wang S; Kobayashi Y; Sughimoto K; Liu H
    Biomed Eng Online; 2024 Jun; 23(1):60. PubMed ID: 38909231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational study.
    Shiba M; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Seko Y; Yamamoto E; Yoshikawa Y; Kitai T; Yamashita Y; Iguchi M; Nagao K; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
    BMJ Open; 2021 Feb; 11(2):e044409. PubMed ID: 33608404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle age serum sodium levels in the upper part of normal range and risk of heart failure.
    Dmitrieva NI; Liu D; Wu CO; Boehm M
    Eur Heart J; 2022 Sep; 43(35):3335-3348. PubMed ID: 35348651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed diagnosis of cardiac amyloidosis in a West African octogenarian.
    Ahadzi D; Yakubu AS; Doku A; Agyekum F; Ofori C; Ayetey H
    Cardiovasc J Afr; 2024 Feb; 34():1-4. PubMed ID: 38407420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.
    Koyama S; Ito K; Terao C; Akiyama M; Horikoshi M; Momozawa Y; Matsunaga H; Ieki H; Ozaki K; Onouchi Y; Takahashi A; Nomura S; Morita H; Akazawa H; Kim C; Seo JS; Higasa K; Iwasaki M; Yamaji T; Sawada N; Tsugane S; Koyama T; Ikezaki H; Takashima N; Tanaka K; Arisawa K; Kuriki K; Naito M; Wakai K; Suna S; Sakata Y; Sato H; Hori M; Sakata Y; Matsuda K; Murakami Y; Aburatani H; Kubo M; Matsuda F; Kamatani Y; Komuro I
    Nat Genet; 2020 Nov; 52(11):1169-1177. PubMed ID: 33020668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction: Results From the PROMIS-HFpEF Study.
    Sanders-van Wijk S; Tromp J; Beussink-Nelson L; Hage C; Svedlund S; Saraste A; Swat SA; Sanchez C; Njoroge J; Tan RS; Fermer ML; Gan LM; Lund LH; Lam CSP; Shah SJ
    Circulation; 2020 Nov; 142(21):2029-2044. PubMed ID: 33034202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART-2 study.
    Fujihashi T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Yamanaka S; Hayashi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    ESC Heart Fail; 2021 Apr; 8(2):1027-1038. PubMed ID: 33377627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.
    Anker SD; Butler J; Filippatos G; Shahzeb Khan M; Ferreira JP; Bocchi E; Böhm M; Brunner-La Rocca HP; Choi DJ; Chopra V; Chuquiure E; Giannetti N; Gomez-Mesa JE; Janssens S; Januzzi JL; Gonzalez-Juanatey JR; Merkely B; Nicholls SJ; Perrone SV; Piña IL; Ponikowski P; Senni M; Seronde MF; Sim D; Spinar J; Squire I; Taddei S; Tsutsui H; Verma S; Vinereanu D; Zhang J; Jamal W; Schnaidt S; Schnee JM; Brueckmann M; Pocock SJ; Zannad F; Packer M;
    Eur J Heart Fail; 2020 Dec; 22(12):2383-2392. PubMed ID: 33251670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training affects hemodynamics and exercise capacity in cases of heart failure with preserved ejection fraction: a non-randomized controlled trial in individuals aged 65-80 years.
    Sugita Y; Ito K; Yoshioka Y; Kudo A; Arakawa S; Sakai S
    Front Cardiovasc Med; 2023; 10():1246739. PubMed ID: 38028475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac remodeling on echocardiogram is related to contrast-associated acute kidney injury after coronary angiography: a cross-section study.
    Chen Q; Li D; Jiang H; Hu T; Tao Y; Du C; Zhang W
    Front Cardiovasc Med; 2023; 10():1173586. PubMed ID: 38028458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure.
    Xanthopoulos A; Katsiadas N; Skoularigkis S; Magouliotis DE; Skopeliti N; Patsilinakos S; Briasoulis A; Triposkiadis F; Skoularigis J
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertensive Heart Failure.
    Triposkiadis F; Sarafidis P; Briasoulis A; Magouliotis DE; Athanasiou T; Skoularigis J; Xanthopoulos A
    J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms.
    Shi Y; Liu C; Yang C; Qiao W; Liu Y; Liu S; Dong G
    Front Cardiovasc Med; 2023; 10():1208370. PubMed ID: 37469482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.